Innovative Tool to Increase Completion of Human Papillomavirus (HPV) Vaccine Series

NACompletedINTERVENTIONAL
Enrollment

365

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions
GARDASIL Vaccination
Interventions
BEHAVIORAL

Computer reminder system

Intervention sites will receive computer kiosk with study specific software to assist in reminding study participants to return for HPV vaccine series

Trial Locations (9)

27514

Planned Parenthood of Central North Carolina, Chapel Hill

28205

Planned Parenthood of North Carolina, Charlotte

60612

Family Planning Clinic of the John H. Stroger Jr. Hospital of Cook County, Chicago

80003

Planned Parenthood of Rocky Mountains, Arvada

80218

Planned Parenthood of Rocky Mountains, Denver

84095

Planned Parenthood Association of Utah, South Jordan

84403

Planned Parenthood Association of Utah, Ogden

85302

Planned Parenthood of Arizona, Glendale

98105

Planned Parenthood of Greater Northwest, Seattle

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Planned Parenthood Federation of America

OTHER

NCT01343485 - Innovative Tool to Increase Completion of Human Papillomavirus (HPV) Vaccine Series | Biotech Hunter | Biotech Hunter